VINCERX PHARMA INC (VINC)
Institutional ownership reported to the SEC as of Q2 2025, across 19 quarters.
1
Reporting holders
$2
Reported value
0.0%
Held as options
-13
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Bank & Trust Co | $2 | 50 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 1 | $2 | 50 | 1 | 0 | 0 | 0.0% |
| Q1 2025 | 14 | $116.8K | 220,626 | 13 | 0 | 1 | 0.0% |
| Q4 2024 | 20 | $1.2M | 4,750,284 | 1 | 3 | 7 | 0.0% |
| Q3 2024 | 24 | $7.5M | 10,460,061 | 3 | 5 | 4 | 0.0% |
| Q2 2024 | 26 | $8.3M | 10,205,337 | 4 | 4 | 8 | 0.0% |
| Q1 2024 | 32 | $40.5M | 8,012,433 | 10 | 8 | 9 | 0.0% |
| Q4 2023 | 28 | $11.4M | 9,655,721 | 1 | 4 | 6 | 0.0% |
| Q3 2023 | 30 | $10.2M | 10,088,255 | 4 | 6 | 8 | 0.0% |
| Q2 2023 | 30 | $14.9M | 11,432,903 | 2 | 4 | 9 | 0.0% |
| Q1 2023 | 29 | $12.6M | 12,092,000 | 1 | 3 | 5 | 0.0% |
| Q4 2022 | 28 | $12.3M | 12,080,342 | 2 | 4 | 11 | 0.0% |
| Q3 2022 | 41 | $20.0M | 14,525,788 | 5 | 7 | 12 | 0.0% |
| Q2 2022 | 44 | $18.4M | 13,944,801 | 6 | 14 | 11 | 0.0% |
| Q1 2022 | 65 | $65.1M | 16,279,178 | 13 | 17 | 13 | 0.0% |
| Q4 2021 | 55 | $156.8M | 15,391,072 | 7 | 29 | 5 | 0.0% |
| Q3 2021 | 55 | $248.9M | 15,435,618 | 9 | 25 | 13 | 0.0% |
| Q2 2021 | 55 | $157.3M | 12,116,423 | 25 | 20 | 7 | 0.0% |
| Q1 2021 | 36 | $171.4M | 8,861,488 | 22 | 7 | 5 | 0.2% |
| Q4 2020 | 18 | $79.8M | 3,803,775 | 16 | 0 | 0 | 0.4% |